Selective gene therapy represents a potent approach in cancer treatment that utilizes a cell’s own nontoxic suicide genes. Currently, the suicide genes under investigation mediate sensitivity by encoding viral or bacterial enzymes that convert inactive prodrug into toxic antimetabolites that inhibit nucleic acid synthesis (1 ,2 ).